Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) testing are transforming diagnostics. New products and support services are providing the critical tools and components which enable clinicians to detect specific biomarkers and target treatments, ultimately resulting in better patient outcomes.
Recent events have increased the global focus and commitment on bringing diagnostic tests to market as quickly as possible as well as the challenges the industry has faced in developing and bringing these diagnostic tests to market in exceptional circumstances. A wealth of technology, diverse expertise in areas such as material science, biochemistry, virology as well as a robust supply of critical components are fundamental to the successful development of every test. Optimizing assays and kits for high sensitivity and accuracy is a common goal for all those involved in the development process. The need for close collaboration between diagnostic developers and component and material providers has never been stronger.
We invite you to our thought-provoking and interactive virtual summit showcasing recently launched technologies, products and solutions supporting the development of diagnostics. Incorporating a program of webinars hosted by leading scientists at the University College London (UCL) and Harvard Medical School, a panel discussion from industry experts from DCN and Sona Nanotech as well as sessions from Cytiva’s own product and application specialists. You will also be able to live chat with our product experts.
If you would like to pre-schedule a 15 minute meeting with one of our Cytiva experts please click here.
Event tracks available:
- Lateral flow design considerations
High performance, diagnostic rapid point-of-care (POC) flow-based tests can quickly deliver reliable results in challenging settings. When designing a new test and designing out a component in an existing test-what are the key considerations and what will be needed in the future?
- Accelerating diagnostic development with custom and design services
Commercializing a test or assay as quickly as possible is critical to success. Find out how diagnostic design services, lyophilization and custom capabilities can provide capacity, resources and expertise to improve speed to market now and in the future.
- Collaborating for effective diagnostic development
Strategic collaboration enables the development of diagnostic tests, assays and service for a wide range of applications. Hear about recent collaborations that have resulted in successful test development and set a path for future development.
- Simplifying your next-generation sequencing (NGS) workflow
High throughput NGS techniques are revolutionizing genomics from massively parallel whole genome sequencing to targeted sequencing approaches. Find out how to simplify your sequencing approaches for more detailed data, better diagnosis, and more targeted treatments to address current and future demands.
- Exploring single-cell omics opportunities
Recent technological advancements have made single-cell omics an increasingly powerful tool for diagnosis, treatment response prediction, and treatment selection, particularly for cancer. Learn about the opportunities for improving results in this growing field.
- Optimizing nucleic acid isolation
Recent years have seen the development and adaptation of several approaches for nucleic acid isolation, aiming to improve speed, throughput, and reproducibility. Find out how to optimize results, particularly for liquid biopsy and viral samples now and in the future.
Sessions will be available for on-demand viewing immediately following the live broadcast.